These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14765833)

  • 21. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL; Corbett TL
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modern aspects of antithrombotic treatment: an introduction.
    Horstkotte D; Piper C
    J Heart Valve Dis; 2004 May; 13(3):314-8. PubMed ID: 15222273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation for patients with atrial fibrillation in ambulatory care settings.
    Niska R; Han B
    J Am Board Fam Med; 2009; 22(3):299-306. PubMed ID: 19429736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
    Parrish RH; Pazdur DE; O'donnell PJ
    Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-management of anticoagulation.
    Levi M
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin resistance: diagnosis and therapeutic alternatives.
    Hulse ML
    Pharmacotherapy; 1996; 16(6):1009-17. PubMed ID: 8947972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin resistance in a patient with short bowel syndrome.
    Brophy DF; Ford SL; Crouch MA
    Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.
    Takahashi H; Echizen H
    Pharmacogenomics J; 2003; 3(4):202-14. PubMed ID: 12931134
    [No Abstract]   [Full Text] [Related]  

  • 31. In-home oral anticoagulation therapy: a specialized program.
    Campbell B
    Caring; 1997 Oct; 16(10):90-2, 94, 96-8. PubMed ID: 10173938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of enzyme induction of warfarin metabolism with recommendations for patient management.
    Cropp JS; Bussey HI
    Pharmacotherapy; 1997; 17(5):917-28. PubMed ID: 9324181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific clinical constellations might mask the genetic over-sensitivity to warfarin.
    Kurnik D; Loebstein R; Halkin H
    Isr Med Assoc J; 2002 Jun; 4(6):475; author reply 475-6. PubMed ID: 12073434
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethnic differences in reactions to drugs and xenobiotics. Caffeine and other drugs.
    Kalow W
    Prog Clin Biol Res; 1986; 214():331-41. PubMed ID: 3523511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variations in warfarin metabolism: why one size doesn't fit all with some drugs.
    De Sevo MR
    Nurs Womens Health; 2010 Apr; 14(2):131-6. PubMed ID: 20409136
    [No Abstract]   [Full Text] [Related]  

  • 36. The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements.
    Weiss P; Halkin H; Almog S
    Thromb Haemost; 1986 Dec; 56(3):371-5. PubMed ID: 3563968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral anticoagulant drugs: pharmacokinetic aspects.
    Breckenridge A
    Semin Hematol; 1978 Jan; 15(1):19-26. PubMed ID: 341326
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacogenetically hazardous drugs: a proposed new scoring method.
    Szórády I; Sánta A
    Acta Physiol Hung; 1991; 77(3-4):305-18. PubMed ID: 1755332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical use of miconazole antifungal oral gel on warfarinized patients: a word of caution.
    Ezsiás A; Wojnarowska F; Juniper R
    Dent Update; 1997 Dec; 24(10):421-2. PubMed ID: 9534418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin resistance and enteral feedings: 2 case reports and a supporting in vitro study.
    Penrod LE; Allen JB; Cabacungan LR
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1270-3. PubMed ID: 11552202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.